Home   /   Pressrelease    /   

Option program for the CEO and...

Option program for the CEO and the deputy CEO

Magnus Nilsson (CEO) has bought 400,000 options and Christoffer Rosenblad (deputy CEO and CFO) has bought 100,000 options via an option program issued by three large shareholders in XVIVO Perfusion AB. Each option gives the right to purchase one XVIVO Perfusion share during a two year period.

The options are valued according to Black-Scholes and gives the right to purchase one XVIVO Perfusion share for SEK 124.00 within a two year period. XVIVO Perfusion AB (publ.) is not the contracting party of this transaction since the options are issued by three large shareholders. The Board of Directors are informed of the transaction and welcomes the option program.

March 22, 2018
Gothenburg
Magnus Nilsson, CEO
XVIVO Perfusion AB (publ)

Fill out the form to watch the video